The study includes 172 adult patients aged 1865 with UC for at least 3 months who have inadequate response to standard treatments including corticosteroids and immunosuppressants, while excluding those with previous biologic use, severe comorbidities, or active infections
Why the new GLP-1 pill is such a big deal The FDA just approved Foundayo
Protocol summary table Diet and lifestyle optimization for thyroid patients on tirzepatide Managing the dual demands of thyroid health and GLP-1 treatment requires thoughtful attention to nutrition, hydration, and daily habits
The intake is short, but having to sign up before seeing prices is still a defect Pricing Breakdown Lab work is not required to start treatment
May 22, 2024: Science Day Canceled in Ozempic Lawsuit, Case Reassignment Possible Science Day has been canceled in the Ozempic Lawsuit